lunes, 24 de junio de 2024
‘We’re failing right now’ in type 2 diabetes, FDA chief says Elizabeth Cooney By Elizabeth Cooney June 21, 2024
https://www.statnews.com/2024/06/21/robert-califf-diabetes-type-2-chronic-disease/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--Clmx5K8Xc7JxuvVCaZAh9CeU2s89QYAqH5MVEaPCPZWm83zb00hat6v1FZztJ7TQ8VmmYGt0tf_TLAxEslHRizLzAtA&_hsmi=312829735&utm_content=312829735&utm_source=hs_email
ONE NOTABLE QUOTE
'We’re failing right now.'
That’s FDA Commissioner Robert Califf, speaking about a lack of progress on type 2 diabetes on Friday at the American Diabetes Association conference. He believes that providers are underutilizing options like bariatric surgery and the new obesity drugs for treating an “epidemic” of type 2 diabetes. Califf expressed more hope for the research happening in type 1 diabetes. Read more on Califf’s comments from STAT’s Liz Cooney.
Here are the dozens of weight loss drugs in development to catch a booming market
Elaine Chen
Allison DeAngelis
J. Emory Parker
By Elaine Chen , Allison DeAngelis , and J. Emory Parker
https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8UKrY8vTzLwdqejKjOmNRcEVV8HI26znkm4qq43-jxvqcCZ8SoqEz_CC-hB2MeaMAunJonuUS47PD4mXQHMm4MUhZ5BQ&_hsmi=312829735&utm_content=312829735&utm_source=hs_email
Sept. 12, 2023
What do new weight loss drugs mean for the future of bariatric surgery?
By Simar BajajAug. 28, 2023
https://www.statnews.com/2023/08/28/obesity-bariatric-surgery-new-weight-loss-drugs/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--mMt9BaJ2wdm7yGsY5DDpsXbPbDoBJnptcZkfQOhkAFcbzECEH5vg9Guf0SIcHMOc2NeVtZtrxQuhqWDx43peWSGiuNw&_hsmi=312829735&utm_content=312829735&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario